Literature DB >> 22008137

[Place of genotyping in addition to the phenotype and the assay of serum α-1 antitrypsin].

Philippe Joly1, Alain Francina, Philippe Lacan, Jessica Heraut, Colette Chapuis-Cellier.   

Abstract

The diagnosis of deficiency of alpha-1 antitrypsin (A1AT) is based on isoelectric focusing of serum proteins and the extent of serum. However, the focusing is technically difficult and a greatly reduced concentration in abnormal A1AT tapeless does not differentiate an unstable variant of a variant called 'null' (that is to say without any phenotypic expression) to 'heterozygous' state. In this study, we compared the results of the assay, the phenotype and genotype of A1AT in 50 patients. Normal A1AT alleles (Pi*M1 to Pi*M4) or loss of the most common (Pi*S and Pi*Z) were clearly identified in phenotyping. However, genotyping was necessary to characterize: (i) certain alleles rarer A1AT (S-Munich, X-Christchurch); (ii) a null allele and; (iii) two new alleles A1AT not yet described in the literature. In conclusion, although the A1AT genotyping is generally not necessary, it is necessary to resolve complex cases and to obtain witnesses validated for isoelectric focusing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008137     DOI: 10.1684/abc.2011.0613

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  2 in total

1.  Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.

Authors:  Philippe Joly; Olivier Guillaud; Valérie Hervieu; Alain Francina; Jean-François Mornex; Colette Chapuis-Cellier
Journal:  Orphanet J Rare Dis       Date:  2015-10-07       Impact factor: 4.123

2.  Description of 22 new alpha-1 antitrypsin genetic variants.

Authors:  Céline Renoux; Marie-Françoise Odou; Guillaume Tosato; Jordan Teoli; Norman Abbou; Christine Lombard; Farid Zerimech; Nicole Porchet; Colette Chapuis Cellier; Malika Balduyck; Philippe Joly
Journal:  Orphanet J Rare Dis       Date:  2018-09-17       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.